Muir-Torre syndrome

From WikiMD.org
Jump to navigation Jump to search

Muir-Torre syndrome (pronunciation: myoor-tor-ay sin-drohm) is a rare, autosomal dominant genetic disorder that is characterized by the occurrence of sebaceous gland tumors and/or keratoacanthomas and internal malignancies. The syndrome is named after the two scientists, Dr. Muir and Dr. Torre, who first described it in 1967.

Etymology

The term "Muir-Torre syndrome" is derived from the names of the two scientists, Dr. Muir and Dr. Torre, who first described the condition in 1967. The term "syndrome" is derived from the Greek word "syndromē", which means "concurrence".

Symptoms

The most common symptoms of Muir-Torre syndrome include the development of sebaceous gland tumors, keratoacanthomas, and internal malignancies. These internal malignancies often involve the gastrointestinal tract, genitourinary tract, and breast. Other symptoms may include weight loss, abdominal pain, and blood in the stool.

Diagnosis

The diagnosis of Muir-Torre syndrome is typically made based on the presence of both sebaceous gland tumors or keratoacanthomas and at least one internal malignancy. Genetic testing may also be used to confirm the diagnosis.

Treatment

Treatment for Muir-Torre syndrome typically involves the surgical removal of tumors and the treatment of internal malignancies. This may include chemotherapy, radiation therapy, or other forms of cancer treatment.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski